NEW YORK, Feb 7 – Population genetics company DNA Sciences said Wednesday that its chief operating officer and head of technology development, Greg Went, resigned.
The Fremont, Calif.-based company said it would not replace Went, who left to “pursue other interests.”
DNA Sciences also announced that it appointed Christopher Burrow to head the company’s clinical research efforts. He will be involved with the company's genetic research and product development programs. He will also work with outside scientific collaborators and medical groups.
Burrow will report to Raymond White, DNA Sciences' chief scientific officer.
DNA Sciences, which recently filed for an IPO, studies the role genes play in diseases such as cancer, asthma, and diabetes. It is also planning to commercialize diagnostic tests.